The Pharmaceutical Services Negotiating Committee (PSNC) has raised concerns over the NHS ad campaign highlighting how community pharmacies can support patients
with non-health advice amidst the growing pressure on pharmacies.
It believes the campaign will only 'worsen' the pressure on pharmacies.
"It is always deeply concerning to see campaigns directing people to pharmacies without any regard for the pressures they are under: it is irresponsible and extremely
unhelpful," said PSNC Chief Executive Janet Morrison.
She called the campaign 'particularly irritating' just weeks after the committee rejected a series of proposals from NHS England and DHSC on relief measures to ease
pressure on pharmacies as being totally inadequate.
"NHS England Board Members have noted the pressure on pharmacies - so why are their teams so often acting to make these pressures worse? We need to see a radical
change in how NHS England treats pharmacies and we're continuing to press for that via our influencing and campaigning work," she added.
The NHS launched the new campaign on Monday (27 February) to highlight how high-street pharmacies can support patients with non-urgent health advice for minor
conditions including coughs, aches and colds.
Dry eye disease, also known as dry eye syndrome, occurs when the eye stops producing enough tears, the tears that are made are of poor quality or the tears
evaporate faster than they should. This causes dryness and irritation of the surface of the eye and results in inflammation, discomfort, and damage.[i]
Symptoms include dry, red, itchy or tired eyes, blurred vision and foreign body sensation. From over-the-counter eye drops and heated eye masks, to eyelid-cleansing
wipes, there are a multitude of options that can be offered to sufferers to provide relief.
As a result of the pandemic and new living and working patterns, the World Health Organization has indicated dry eye disease is on the rise. This can be attributed to various lifestyle factors including increased screen use and wearing of face masks.
An increase in sufferers seeking advice on the condition in pharmacies has also been reported. It is no surprise that sufferers will turn to their pharmacists for help, support and information on the condition and how it can be managed by treatment options available over-the-counter.
There are many reasons why people might need help with their dental problems. Maybe they don't have insurance, or maybe they just don't have the money to go to
a dentist. In these
cases, the pharmacy can be a great option. Pharmacists can provide a variety of services that can help people with their dental problems, including over-the-counter
medications and advice on how to take care of teeth and gums. In this blog post, we will discuss some of the ways that pharmacies can help you take care of your
teeth! So, whether you have a toothache, cavities, or bad breath, a pharmacy can be a great place to turn.
1) OVER-COUNTER MEDICATIONS
One of the most common services that pharmacies provide is the sale of over-the-counter medications. These medications are designed to be taken for short periods of
time and can help with a variety of dental problems. For example, if you have a toothache, you can buy an antiseptic rinse or analgesic gel that can help relieve
the pain. If you have bad breath, you can buy mouthwash or breath fresheners that will help mask the odor. And if you have cavities, you can purchase fluoride
rinses or gels that can help with decay prevention. If you are worried about the cost of dentists, these medications can be a great way to get the relief you need
without breaking the bank. However, it doesn't mean that you should neglect regular dental visits!
2) PROVIDE YOU WITH EDUCATION
Another way pharmacy can help you with your dental problems is through advice and education. Pharmacists are trained to provide general information on oral hygiene
and health and can help you make educated decisions about which products to buy. They can also provide recommendations on how often you should brush and floss your
teeth, as well as advice on diet and lifestyle choices that can help prevent dental problems. In addition, some pharmacies may even have an oral health specialist
on staff who can answer any questions you might have about your teeth or gums
In a move to make healthcare more accessible, the Department of Health and Social Care (DHSC) has announced plans to empower pharmacy technicians, dental
therapists, and hygienists with enhanced authority following two public consultations run by the government in 2023.
Revealed by Primary Care Minister Andrea Leadsom on Thursday 28th March, this strategic decision promises to usher in "a faster, simpler, and fairer access to
primary care" by granting pharmacy professionals "the ability to both supply and administer medications".
Based on the public consultations that garnered widespread support, with 97% backing the empowerment of dental hygienists and therapists and 84% favouring similar
rights for pharmacy technicians, the new reform is aimed to cut through bureaucratic red tape and bolster efficiency in patient care.
Dental hygienists and therapists, under the proposed change, will be empowered to administer select medications, including pain relief and fluoride, without the
need for dentist approval.
More than a third of pharmacists who participated in a survey said they have seen an increase in patients declining prescriptions due to the cost in the
last 12 months.
The survey was jointly conducted by the Pharmacists' Defence Association (PDA) and the Royal Pharmaceutical Society (RPS), extending their support for the
Prescription Charges Coalition (PCC).
Responding to the survey, 90 per cent of pharmacists admitted seeing cases where patients decline all the medicines on a prescription due to cost.
Nearly all respondents said they have seen cases where patients declined some of their prescribed medicines and more than a quarter of them have experienced
such situation often.
They have warned of the impact of prescription charges as patients are denying vital medicines, including those for blood pressure and mental health, inhalers,
antibiotics, pain relief, and statins, which can have potential consequences for the individual's health.
The incredible consequences that drug misuse has imposed on humans in the last few years make it one of the most pressing issues facing such nations.
A person who is addicted to drugs or alcohol often turns to these substances as a crutch while they're going through tough times. Taking the drug regularly
becomes habitual since it provides short-term relief without permanently resolving the issue. An important part of becoming sober is learning to substitute
better routines for the addict's old, harmful ones. These self-care routines and healthy habits are much better ways to deal with stress. Here we will explain
how healthy behavior throughout addiction recovery is simply one of many methods to adapt to life after treatment.
Physical Activity
Scientific studies have shown that physical activity increases levels of two hormones. dopamine and serotonin, which are linked to better mood. A more positive
outlook, restful sleep, and enhanced general health are all possible outcomes of these hormones. In the early stages of your rehabilitation, it is wise to start
an exercise regimen that you have never done before. You may find new sober friends and interactions, as well as inspiration to improve your physical health, by
connecting with other people who share your interests in physical activity. In the early stages of recovery, having sober friends may be really helpful since it
allows you to connect with those who understand what you're going through. Friendships formed in early recovery often continue long after the addict has left the
program, according to many people in recovery.
With the UK General Election set for 4 July, pharmacy bodies are actively engaging with all political parties to secure support for the community pharmacy
sector. They are pressing parties to address urgent issues such as pharmacy closures and medicine shortages.
"The upcoming general election is a critical opportunity for us to strengthen supporters of community pharmacy in readiness for the new Parliament," said Janet
Morrison, chief executive of Community Pharmacy England (CPE).
She stressed the need for unity within the sector in advocating for community pharmacy and raising awareness of the issues with election candidates from all parties.
As the general election approaches, CPE has called upon all political parties to support pharmacies by "introducing a long-term sustainable funding model and
reviewing the medicines supply chain, including much-needed short-term relief measures."
Whenever you start experiencing a heart-burning sensation, immediately consume a teaspoon of mustard (one thing should keep in mind that it must be of finest quality and have yellow color).
COVID emergency relief funds restrict medical billing services from sending surprise bills to patients on behalf of clinicians. Does this mean surprise billing is about to end?
Consumer health company Haleon, formerly known as GSK, claims that pain's emotional and life impact has grown by nearly 25 per cent in the past decade.
The company has launched a campaign #ListenToPain to personalise patients' pain management through a series of practical tools and resources.
The campaign was introduced on 28 September which focused on enabling the HCPs to maximise their time with patients and understand their pain experience - providing
them with an effective treatment plan.
The new data has been obtained through the fifth edition of the Haleon Pain Index (HPI). This social study measured the impact of individuals' everyday lives,
their
health, their feelings, their emotions, motivations and behaviours.
They have spoken to more than 87,000 people around the world since their first edition in 2014 - HPI 1 (The State of Pain), which later progressed over the years
from HPI 2 (Impact of Pain) in 2017, then HPI 3 (Managing Pain) in 2018, to HPI 4 (Treatment Journey), and finally HPI 5 (Pain and Inclusivity) in 2023.
The Pharmacists' Defence Association (PDA) has announced that it will support its member impacted by the decision to close 300 more Boots pharmacies.
After the announcement of closure of 300 Boots pharmacies over the next year, the association believes this is approximately one out of every eight current
Boots pharmacy locations.
The company has insisted that the objective of this exercise is not to make existing pharmacist employees redundant, and they hope to be able to redeploy
individuals into nearby alternative locations. However, PDA believes that it is unlikely that suitable alternative roles will be available for all and
redundancy is a possibility for some.
The PDA Union will provide pharmacists with information, support, and representation as part of the recognition agreement so that members are aware of and
can exercise their rights at work. PDA officials will be in continued dialogue with the company throughout this closure programme.
The Medicines and Healthcare products Regulatory Agency (MHRA) has cautioned people to stop using certain eye gels, highlighting a potential risk of
microbial contamination that can cause an infection.
As a precaution, the agency on Friday announced recall of specific batches of carbomer-containing lubricating eye gels branded Aacarb, Aacomer and Puroptics,
which are generally used to relieve the symptoms of dry eye.
Burkholderia cenocepacia is suspected to have caused the microbial contamination, and the issue was raised after an ongoing investigation conducted by UK Health
Security Agency (UKHSA) identified a small number of cases of infection.
Investigations are on to determine if there is a link between these products and the infections which have been identified.
Meanwhile, retailers have been told to withdraw the affected products, and users are asked to return their product to the place of purchase immediately.
Welcome to our comprehensive guide on understanding and managing musculoskeletal pain. This type of discomfort, often arising from an injury to the
body's muscles, joints, tendons, ligaments, or nerves, can lead to significant functional impairment and reduced quality of life. In the following sections,
we'll delve into the causes, diagnosis, and various treatment options for musculoskeletal pain, equipping you with the knowledge you need to manage and
alleviate your symptoms effectively.
Consult a Medical Professional
While this guide offers a general understanding of musculoskeletal pain, it is critical to consult with a healthcare professional for any pain or discomfort
you may be experiencing. Health practitioners can offer a proper diagnosis and develop a personalized treatment plan that considers your specific symptoms,
condition, and overall health. For example, the best physical therapists can suggest a variety of exercises and stretches to help strengthen muscles and
alleviate pain. Some pain may require surgery, while others can be managed with medication or physical therapy. Your medical provider will work with you to
find the most effective treatment plan.
A newly licensed 1mg/ml Omeprazole Powder for Oral Suspension has been developed by Rosemont Pharmaceuticals to meet the special needs of babies
from 1 to 12 months old who have gastro-oesophageal reflux disease (GORD). In infants, the symptoms of GORD can be particularly distressing for both the child
and parent.
Previously, Rosemont Omeprazole Powder for Oral Suspension has been available in 2mg/ml and 4mg/ml strengths. However, the addition of the new 1mg/ml product
ensures that the needs of all patient groups with GORD are sufficiently met.
The Rosemont range of Omeprazole Powder for Oral Suspension products are the only PPIs (proton pump inhibitors) indicated for use in babies from 1 month to
1 year. Symptoms of GORD in infants are usually resolved by 1 year of age1, so it is key that there is a licensed treatment option available for the 1 to 12 month
patient group.
A newly licensed 1mg/ml Omeprazole Powder for Oral Suspension has been developed by Rosemont Pharmaceuticals to meet the special needs of babies from 1 to 12
months old who have gastro-oesophageal reflux disease (GORD). In infants, the symptoms of GORD can be particularly distressing for both the child and parent.
Previously, Rosemont Omeprazole Powder for Oral Suspension has been available in 2mg/ml and 4mg/ml strengths. However, the addition of the new 1mg/ml product
ensures that the needs of all patient groups with GORD are sufficiently met.
The Rosemont range of Omeprazole Powder for Oral Suspension products are the only PPIs (proton pump inhibitors) indicated for use in babies from 1 month to 1 year.
Symptoms of GORD in infants are usually resolved by 1 year of age1, so it is key that there is a licensed treatment option available for the 1 to 12 month patient
group.